Covered recipient · General Payments record
BHUMIBEN M PATEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024–2025
$351.03
- Reported across 16 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): (records>=3 OR total>=100) AND records>=2 AND NPI identity (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $337.44 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $100.15 | 5 |
| Corcept Therapeutics | $83.81 | 3 |
| Gilead Sciences, Inc. | $32.17 | 1 |
| GlaxoSmithKline, LLC. | $26.77 | 1 |
| Lilly USA, LLC | $24.82 | 1 |
| DEXCOM, INC. | $21.57 | 1 |
| Seqirus USA Inc | $18.18 | 1 |
| Amgen Inc. | $15.55 | 1 |
| Organon LLC | $14.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.55 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228910751 | CMS |
| Corcept Therapeutics | $29.76 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214137534 | CMS |
| Corcept Therapeutics | $31.98 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214137571 | CMS |
| Corcept Therapeutics | $22.07 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214137635 | CMS |
| Dexcom, Inc. | $21.57 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250545876 | CMS |
| Gilead Sciences, Inc. | $32.17 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234427464 | CMS |
| GlaxoSmithKline, LLC. | $26.77 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190613804 | CMS |
| Lilly USA, LLC | $24.82 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186943959 | CMS |
| Novo Nordisk Inc | $23.60 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188639921 | CMS |
| Novo Nordisk Inc | $21.66 | 07/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189149788 | CMS |
| Novo Nordisk Inc | $21.18 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188469099 | CMS |
| Novo Nordisk Inc | $16.24 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188943408 | CMS |
| Novo Nordisk Inc | $17.47 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188695042 | CMS |
| Organon LLC | $14.42 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237669568 | CMS |
| Seqirus USA Inc | $18.18 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201095854 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.